Free Trial
OTCMKTS:HBPCF

Helix BioPharma (HBPCF) Stock Price, News & Analysis

Helix BioPharma logo
$0.45 0.00 (0.00%)
(As of 11/22/2024 ET)

About Helix BioPharma Stock (OTCMKTS:HBPCF)

Key Stats

Today's Range
$0.45
$0.45
50-Day Range
$0.45
$0.92
52-Week Range
$0.45
$0.92
Volume
N/A
Average Volume
388 shs
Market Capitalization
$22.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Receive HBPCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

HBPCF Stock News Headlines

Helix BioPharma Secures U.S. Patent for Cancer Therapy
Helix BioPharma Highlights L-DOS47 at World ADC
2025: Digital Asset Insights You Need to Know
Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.
Helix BioPharma Corp HBPCD
Helix BioPharma Corp. Reports Voting Results
See More Headlines

HBPCF Stock Analysis - Frequently Asked Questions

Helix BioPharma's stock was trading at $0.1450 at the beginning of 2024. Since then, HBPCF stock has increased by 213.7% and is now trading at $0.4549.
View the best growth stocks for 2024 here
.

Helix BioPharma Corp. (OTCMKTS:HBPCF) issued its quarterly earnings data on Thursday, October, 24th. The company reported ($0.08) earnings per share (EPS) for the quarter.

Shares of HBPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
10/24/2024
Today
11/23/2024
Fiscal Year End
7/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:HBPCF
CIK
N/A
Employees
9
Year Founded
N/A

Profitability

Net Income
$-6,820,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
45,296,000
Market Cap
$22.30 million
Optionable
Not Optionable
Beta
0.06
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (OTCMKTS:HBPCF) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners